Trial NCT02607813

View at ClinicalTrials.gov 
Org. Study IDs: CLXH254X2101
Secondary IDs: 2015-003421-33

Last trial update was posted on 2022-12-21

MeSH Interventions

Naporafenib Spartalizumab

MeSH Conditions


Other Conditions

Melanoma NSCLC Other Solid Tumors Ovarian Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID